× |
|
A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction PDF |
$40.00 |
|
$40.00 |
× |
         |
A New Prediction Model for Evaluating Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
× |
         |
Memantine for Fragile X-Associated Tremor/Ataxia Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
× |
         |
Reducing Dropout in Treatment for Depression: Translating Dropout Predictors Into Individualized Treatment Recommendations PDF |
$40.00 |
|
$40.00 |
× |
         |
Association Between DβH 5' ²-Insertion/Deletion Polymorphism and Cognition in Patients With Chronic Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
         |
Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia: A Voxel-Based Diffusion Tensor Imaging Study PDF |
$40.00 |
|
$40.00 |
× |
         |
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs PDF |
$40.00 |
|
$40.00 |
× |
         |
Prognostic Subgroups for Remission and Response in the Coordinated Anxiety Learning and Management (CALM) Trial PDF |
$40.00 |
|
$40.00 |
× |
         |
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF |
$40.00 |
|
$40.00 |
|